Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search History (1)

Search Criteria

  1. Client, organization or corporation number: 360616
Share this search Create an alert
Start over
Modify criteria

Refine registrations results by

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Monthly communication reports (91)
Results: 1-50 | Export
  1. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2024-03-27
    Posted: 2024-04-15
    Designated public office holders:
    • Sharon Burey, Senator | Senate of Canada
    Subject matters:
    • Health
      •
  2. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2024-03-19
    Posted: 2024-04-15
    Designated public office holders:
    • Randy Hoback, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • International Trade
      •
  3. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2024-03-13
    Posted: 2024-04-15
    Designated public office holders:
    • Jade Mallette, Director of Parliamentary Affairs, Office of the Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
      •
  4. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2024-02-28
    Posted: 2024-03-15
    Designated public office holders:
    • Shuvaloy Majumdar, Member of Parliament | House of Commons
    Subject matters:
    • Health
      •
  5. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2023-12-08
    Posted: 2024-01-15
    Designated public office holders:
    • Eshan Naik, Director of Policy, Office of the Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
      •
  6. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2023-11-15
    Posted: 2023-12-15
    Designated public office holders:
    • Connor MacDonald, Policy Advisor | House of Commons
    • Jwane Izzetpanah, Manager of Stakeholder Relations | House of Commons
    Subject matters:
    • Health
      •
  7. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2023-11-14
    Posted: 2023-12-15
    Designated public office holders:
    • Nancy Hamzawi, Executive Vice President | Public Health Agency of Canada (PHAC)
    • Marie-Pier Fontaine, Senior Policy Advisor, Deputy Minister's Office | Health Canada (HC)
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    • Michael Collins, Vice-President, Health Promotion and Chronic Disease Prevention Branch | Public Health Agency of Canada (PHAC)
    • Celia Lourenco, Acting Associate Assistant Deputy Minister, Health Products and Food Branch | Health Canada (HC)
    Subject matters:
    • Health
      •
  8. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2023-11-14
    Posted: 2023-12-15
    Designated public office holders:
    • Ritu Banerjee, Assistant Deputy Minister, Office of Life Science and Biomanufacturing Readiness | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Office of Life Science and Biomanufacturing Readiness | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Research and Development
    • Health
      •
  9. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2023-11-07
    Posted: 2023-11-15
    Designated public office holders:
    • Luc Theriault, Member of Parliament | House of Commons
    Subject matters:
    • Health
      •
  10. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2023-11-07
    Posted: 2023-12-15
    Designated public office holders:
    • Eshan Naik, Director of Policy, Office of the Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
      •
  11. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2023-11-07
    Posted: 2023-12-15
    Designated public office holders:
    • Jennifer Miller, Assistant Secretary | Privy Council Office (PCO)
    • Jeff Waring, Associate Assistant Secretary | Privy Council Office (PCO)
    Subject matters:
    • Health
      •
  12. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2023-11-07
    Posted: 2023-12-15
    Designated public office holders:
    • Rechie Valdez, Minister of Small Business | Innovation, Science and Economic Development Canada (ISED)
    • Chris Zhou, Senior Policy and Atlantic Advisor | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
      •
  13. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2023-11-06
    Posted: 2023-12-15
    Designated public office holders:
    • Suzy McDonald, Associate Deputy Minister | Finance Canada (FIN)
    Subject matters:
    • Health
      •
  14. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2023-11-06
    Posted: 2023-12-15
    Designated public office holders:
    • Ben Chin, Senior Advisor | Prime Minister's Office (PMO)
    Subject matters:
    • Health
      •
  15. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2023-11-06
    Posted: 2023-12-15
    Designated public office holders:
    • Josh Dadjo, Director of Parliamentary Affairs | Senate of Canada
    Subject matters:
    • Health
      •
  16. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2023-10-13
    Posted: 2023-11-15
    Designated public office holders:
    • Eshan Naik, Director of Policy, Office of the Minister of Health | Health Canada (HC)
    • Chelsea Madryga, Policy Advisor, Office of the Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
      •
  17. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2023-09-19
    Posted: 2023-10-16
    Designated public office holders:
    • Michael Collins, A/Vice-President, Health Promotion and Chronic Disease Prevention Branch | Public Health Agency of Canada (PHAC)
    • David Luchuk, A/Director, Health Promotion and Chronic Disease Prevention Branch, Centre for Chronic Disease Prevention and Health Equity, Policy and Engagement Division | Public Health Agency of Canada (PHAC)
    • Danna Campbell, Director, Partnerships & Strategies, Health Promotion and Chronic Disease Prevention Branch | Health Canada (HC)
    Subject matters:
    • Health
      •
  18. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2023-05-29
    Posted: 2023-06-15
    Designated public office holders:
    • Stephen Ellis, Member of Parliament, Cumberland-Colchester | House of Commons
    Subject matters:
    • Health
      •
  19. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2023-05-04
    Posted: 2023-06-15
    Designated public office holders:
    • Benoit Leduc, Manager, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
    • Ritu Banerjee, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
    • Health
      •
  20. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2023-05-03
    Posted: 2023-06-15
    Designated public office holders:
    • Michael Collins, A/ Associate Deputy Minister, Health Promotion and Chronic Disease Prevention Branch | Public Health Agency of Canada (PHAC)
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    • Eric Belair, Associate Assistant Deputy Minister, Strategic Policy Branch | Health Canada (HC)
    Subject matters:
    • Health
      •
  21. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2023-04-12
    Posted: 2023-05-15
    Designated public office holders:
    • Jamie Kippen, Chief of Staff, Office of the Minister | Health Canada (HC)
    • Sandenga Yeba, Deputy Director of Policy, Minister's Office | Health Canada (HC)
    Subject matters:
    • Health
      •
  22. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2023-03-29
    Posted: 2023-04-15
    Designated public office holders:
    • Razan Shahin, Manager, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Caroline Menard, Manager, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
    • Research and Development
      •
  23. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2023-03-27
    Posted: 2023-04-15
    Designated public office holders:
    • Sarah MacDonald, Special Assistant (Assistant to the Parliamentary Secretary and Parliamentary Affairs) | Innovation, Science and Economic Development Canada (ISED)
    • Andy Fillmore, Parliamentary Secretary to the Minister of Innovation, Science and Industry | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
    • Research and Development
      •
  24. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2023-03-21
    Posted: 2023-04-15
    Designated public office holders:
    • Chelsea Madryga, Parliamentary Secretary Assistant | Health Canada (HC)
    • Adam van Koeverden , Parliamentary Secretary | Health Canada (HC)
    Subject matters:
    • Health
      •
  25. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2023-03-06
    Posted: 2023-04-15
    Designated public office holders:
    • Bianca Hossain, Policy Advisor, Office of the Minister of Innovation, Science and Industry | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
    • Health
      •
  26. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2023-02-16
    Posted: 2023-03-15
    Designated public office holders:
    • Benoit Leduc, Manager, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Caroline Menard, Manager, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
    • Economic Development
      •
  27. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2023-02-10
    Posted: 2023-02-15
    Designated public office holders:
    • Kaitlin Blackhall, Manager, Strategic Policy | Employment and Social Development Canada (ESDC)
    • Patrick Verreault, Deputy Director, Food Policy Division | Agriculture and Agri-Food Canada (AAFC)
    • Marebame Longe, Manager, Strategic Policy | Employment and Social Development Canada (ESDC)
    • Poppy Vineberg, Director, Strategic Horizontal Social Policy | Employment and Social Development Canada (ESDC)
    • Jason Baillargeon, Director, Food Policy Division | Agriculture and Agri-Food Canada (AAFC)
    • Erin Krzyzanowski, Manager, Social Development Policy | Employment and Social Development Canada (ESDC)
    • An Brian A Huynh, Junior Policy Analyst, Social Development Policy | Employment and Social Development Canada (ESDC)
    Subject matters:
    • Health
      •
  28. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2022-12-13
    Posted: 2022-12-15
    Designated public office holders:
    • Adam van Koeverden, , Parliamentary Secretary to the Minister of Health and to the Minister of Sport | House of Commons
    Subject matters:
    • Health
      •
  29. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2022-11-25
    Posted: 2022-12-15
    Designated public office holders:
    • David Luchuk, Manager, Centre for Chronic Disease Prevention and Health Equity | Public Health Agency of Canada (PHAC)
    • Annie Comtois, Acting Executive Director, EXECUTIVE DIRECTOR OFFICE BUREAU DE LA DIRECTRICE EXÉCUTIVE EDO-BDE | Public Health Agency of Canada (PHAC)
    Subject matters:
    • Health
      •
  30. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2022-09-26
    Posted: 2022-12-15
    Designated public office holders:
    • Pamela Turpin, Manager | Public Health Agency of Canada (PHAC)
    • Annie Comtois, Director, Programs and Performance, Centre for Chronic Disease Prevention and Health Equity | Public Health Agency of Canada (PHAC)
    • Mark Nafekh, Director General, Centre for Chronic Disease Prevention and Health Equity | Public Health Agency of Canada (PHAC)
    • Tasha Stefanis, Associate Vice President, Health Promotion and Chronic Disease Prevention | Public Health Agency of Canada (PHAC)
    Subject matters:
    • Health
      •
  31. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2022-08-30
    Posted: 2022-12-15
    Designated public office holders:
    • Nathanielle Morin, Policy Advisor, Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
      •
  32. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2022-07-21
    Posted: 2022-12-15
    Designated public office holders:
    • Mark Nafekh, Director General, Centre for Chronic Disease Prevention and Health Equity | Public Health Agency of Canada (PHAC)
    Subject matters:
    • Health
      •
  33. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2022-04-25
    Posted: 2022-12-15
    Designated public office holders:
    • Patrick Delorme, Policy Analyst, PHAC | Public Health Agency of Canada (PHAC)
    • Nolan D’Souza, Program/Policy Fellow, PHAC | Public Health Agency of Canada (PHAC)
    Subject matters:
    • Health
      •
  34. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2022-04-05
    Posted: 2022-12-15
    Designated public office holders:
    • Kathy Thompson, Executive Vice-President of the Public Health Agency of Canada, PHAC | Public Health Agency of Canada (PHAC)
    Subject matters:
    • Health
      •
  35. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2022-04-04
    Posted: 2022-12-15
    Designated public office holders:
    • Adam Van Koeverden, Member of Parliament, Parliamentary Secretary to the Minister of Health and Sport | House of Commons
    • Heather Jeffrey, Associate Deputy Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
      •
  36. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2022-03-15
    Posted: 2022-12-15
    Designated public office holders:
    • Stephen Ellis, Member of Parliament, Cumberland-Colchester | House of Commons
    Subject matters:
    • Health
      •
  37. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2022-03-10
    Posted: 2022-03-10
    Designated public office holders:
    • Michael Barrett, Member of Parliament | House of Commons
    Subject matters:
    • Health
      •
  38. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2022-02-28
    Posted: 2022-03-09
    Designated public office holders:
    • Lindsay Mathyssen, Member of Parliament | House of Commons
    Subject matters:
    • Health
      •
  39. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2022-02-28
    Posted: 2022-03-09
    Designated public office holders:
    • Carol Hughes, Member of Parliament | House of Commons
    Subject matters:
    • Health
      •
  40. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2022-02-25
    Posted: 2022-03-09
    Designated public office holders:
    • Nathanielle Morin, Policy Advisor, Minister's Office | Health Canada (HC)
    Subject matters:
    • Health
      •
  41. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2022-02-22
    Posted: 2022-03-09
    Designated public office holders:
    • Rebecca Caldwell, Senior Policy Advisor | Prime Minister's Office (PMO)
    Subject matters:
    • Health
      •
  42. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2022-02-15
    Posted: 2022-03-09
    Designated public office holders:
    • Ziad Aboultaif, Member of Parliament | House of Commons
    Subject matters:
    • Health
      •
  43. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2021-11-23
    Posted: 2021-12-15
    Designated public office holders:
    • Chris d'Entremont, Member of Pariament | House of Commons
    Subject matters:
    • Health
      •
  44. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2021-11-05
    Posted: 2021-11-16
    Designated public office holders:
    • Sonia Sidhu, Member of Parliament | House of Commons
    Subject matters:
    • Health
      •
  45. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2021-04-01
    Posted: 2021-05-15
    Designated public office holders:
    • Marie-France Lalonde, Member of Parliament, Orléans | House of Commons
    Subject matters:
    • Health
    • Industry
      •
  46. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2021-03-22
    Posted: 2021-04-15
    Designated public office holders:
    • Marie-France Lalonde, Member of Parliament | House of Commons
    Subject matters:
    • Health
      •
  47. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2021-02-08
    Posted: 2021-03-15
    Designated public office holders:
    • Scott Aitchison, Member of Parliament, Parry Sound—Muskoka | House of Commons
    Subject matters:
    • Arts and Culture
    • Health
      •
  48. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2021-01-18
    Posted: 2021-02-15
    Designated public office holders:
    • Sonia Sidhu, Member of Parliament, Brampton South | House of Commons
    Subject matters:
    • Research and Development
    • Health
      •
  49. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2020-10-29
    Posted: 2020-11-16
    Designated public office holders:
    • Chris D'Entremont, Member of Parliament, West Nova | House of Commons
    Subject matters:
    • Research and Development
    • Arts and Culture
    • Health
      •
  50. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2020-10-26
    Posted: 2020-11-16
    Designated public office holders:
    • Helena Jaczek, Member of Parliament, Markham—Stouffville | House of Commons
    Subject matters:
    • Arts and Culture
    • Science and Technology
    • Health
      •
Date Modified: